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PREFACE
This thesis includes research undertaken to gain a clearer understanding of the
effects of the Bacillus anthracis enzymes ATCase and DHOase in pyrimidine
biosynthesis. The biochemical and structural aspects given by these enzymes is
important to human health and will hopefully lead to a better understanding of the
treatment of diseases such as bacteremia and anthrax.
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CHAPTER 1: INTRODUCTION
Anthrax
Anthrax is an infection caused by Bacillus anthracis (BCN). There are four types
of anthrax infection: skin, lungs, intestinal, and injection. The most common form is skin
anthrax. The most fatal is lung anthrax. Anthrax is typically characterized by a swollen
blister or ulcer with a black center. This is often accompanied by fever, chest pain,
shortness of breath, abscesses, diarrhea, nausea, and/or vomiting depending on the type
of anthrax exhibited. This disease is not spread through direct human to human
interaction, but rather through the exposure to bacterial spores. Anthrax is a relatively
rare disease, but it is seen most frequently in Africa and parts of Asia. A vaccine exists
for anthrax. This serious zoonotic disease is mostly associated with animals.[1] However,
anthrax also infects humans. Anthrax infection is expressed in four different forms. The
four forms are skin lesions or cutaneous anthrax, lung or pulmonary anthrax,
gastrointestinal anthrax, and anthrax from injections. The most common form of anthrax
is cutaneous anthrax of the skin. Cutaneous anthrax is also considered to be the least
dangerous. Cutaneous anthrax typically develops within 1 to 7 days. The most dangerous
form of anthrax is pulmonary anthrax of the lung. It can take up to two months to fully
develop. Gastrointestinal anthrax is relatively rare but takes anywhere from 1 to 7 days
to develop. Injection anthrax has never been reported in the United States. The disease
is spread when Bacillus anthracis spores enter the body. [2] Bacillus anthracis is a gram
positive, rod shaped bacteria. There has been research into the use of anthrax as a
biochemical weapon and has been seen in bioterrorism. [3] Lung anthrax is especially
used in biowarfare. [4] It can be delivered as an aerosol and spread through the air.
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Therefore, anthrax has been a hot topic of research interest. If anthrax is left untreated, it
is usually fatal. [5] In addition to anthrax, bacteremia is another disease caused by
Bacillus anthracis. [6] This is of high importance in the hospital setting, as it is a cause of
mortality in medical facilities.
Bacteremia
Bacteremia, also called septicemia, is the presence of bacteria in the bloodstream.
When bacteria enter the bloodstream, it results in systemic inflammation and septic shock
leading to death. It develops when bacteria evade the immune response mechanisms in
the body. [7] Specifically, when certain bacteria, such as Bacillus anthracis, get into the
bloodstream, the growth is exponential. Bacteremia can start in multiple ways from a
simple cut to medical procedures. Therefore, bacteremia is most common in a medical
facility. Bacteremia is commonly confused with sepsis. Sepsis occurs when bacteria enter
the body and causes inflammation and coagulation. [8] Specifically, it causes the release
of proinflammatory cytokines, procoagulants, and adhesion molecules. Sepsis can lead
to a precipitous decrease in blood pressure, called septic shock, which is often fatal. It is
characterized by fever, and heavy breathing. Whereas bacteremia can vary in urgency,
sepsis is almost always severe. Currently, antibiotics can be used to treat sepsis and
bacteremia, but no cure exists. With the rise in antibiotic resistant bacteria, new and
improved antibiotics and preventative measures must be made.
Pyrimidine Biosynthesis
Nucleoside antibiotics are products that block or destroy the complex
regulatory mechanisms necessary for bacterial survival in a host. [9] Pyrimidine
biosynthesis is essential to all living organisms, including bacteria. Pyrimidine
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biosynthesis could potentially be inhibited by an antibiotic, thus killing the bacteria that
was causing infection. The production of such an inhibitor may ultimately lead to the
development of new treatments for bacteremia and sepsis. There are many enzymes
required for efficient and proper pyrimidine biosynthesis. Two that are very important and
will be discussed in this thesis is aspartate transcarbamoylase (ATCase) and
dihydroorotase (DHOase). ATCase plays an important role in not only pyrimidine
biosynthesis production, but also in the mechanistic regulation of de novo synthesis.
DHOase, however, is unregulated. Pyrimidines are nitrogen containing heterocyclic
compounds with basic properties. [10] The nucleobases, cytosine, thymine, and uracil are
nucleic acid derivatives of pyrimidines. These are the “building blocks of life” and are
needed for metabolic functions, such as DNA replication and formation. In order for
bacteria to survive in the blood stream, basic metabolic functions must be conserved.
Bacteria can utilize some nutrients in the host’s bloodstream, but other nutrients need to
be produced de novo. The production of pyrimidines is one such mechanism that is critical
for bacterial growth in blood. [11] Pyrimidines are not readily available in blood, so
bacteria must rely on their own production of pyrimidines to survive in a host environment
There are two ways to make pyrimidines. One is through the salvage pathway, and the
other is de novo. However, the precursors for the salvage pathway are too low in the
blood stream. Therefore, bacteria rely solely on de novo synthesis. ATCase and DHOase
are important enzymes in the biosynthesis of pyrimidines in bacteria and consequentially
can be a drug design target. [12] Thus, the creation of an antibiotic that targets ATCase
or DHOase could cure anthrax disease or bacteremia caused by Bacillus anthracis.
Previous studies have also showed that a complex between ATCase and DHOase forms
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in other bacterial species, such as Aquifex aeolicus. [13] Other studies show that in some
microorganisms there is an active DHOase and in others there is a pseudo DHOase which
retains the structure but has no activity. [14] However, the DHOase in Bacillus anthracis
is indeed active.
Aspartate Transcarbamoylase
Aspartate transcarbamyolase is the enzyme protein that catalyzes the first step in
production of pyrimidines. It condenses L-aspartate and carbamoyl phosphate into Ncarbamy-L-aspartate and inorganic phosphate. In E.coli the following statements about
ATCase regulation are true. [15] Cytosine triphosphate and uridine triphosphate (CTP
and UTP) are products of pyrimidine synthesis. CTP decreases activity of ATCase.
Adenine triphosphate (ATP) is a product of purine synthesis (a similar yet opposite
synthetic mechanism). ATP increases the activity of ATCase. Thus, ATCase’s allosteric
regulation is seen. In E. coli, it consists of two trimeric catalytic subunits and 3 dimeric
regulatory subunits. [16] Yet, this structural composition varies between species. [17]
Some are just catalytic trimers, not associated with any function. Some have regulatory
subunits, others like the ones I have studied in this thesis have an active DHOase or an
inactive pseudo DHOase. Others associate with carbamoyl phosphate synthetase.
Mammalian ATCase is a part of CAD. CAD is a 240-kDa polypeptide with many functions.
[18] In Pseudomonas aeruginosa, active ATCase contains six copies of a 36-kDa catalytic
chains and six copies of a 45-kDa pseudo DHOase. [19] In E. coli, ATCase contains a
catalytic center and an allosteric site. The protein structure for ATCase in BCN has yet to
be determined.
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Dihdydroorotase
Dihydroorotase (DHOase) is a member of the MEROPS peptidase family M38
(clan MJ). DHOase is a dimeric molecule in most organisms. It also has identical chains
of approximately 400 amino acids. [20] DHOase catalyzes the third step in the de novo
biosynthesis of pyrimidines. [21] It converts ureidosuccinic acid (N-carbamoyl-Laspartate) into dihydroorotate and requires one or two zinc atoms for catalytic activity in
all species. [22]

CHAPTER 2: RESEARCH DESIGN
Materials
The reagents used in this project were sourced as follows: B-D Chemicals: yeast
extract, tryptones; BioRad: Tris Chloride, Acrylamide; Fisher: HCL, Bovine serum
albumin; Gold Bio: Ampicillin, IPTG, DTT; Invitrogen: Competent BL21 E. Coli cells,
SDS, TEM-Ed; Lucigen: Recovery media; Mallinckrodt: Nickel (II) chloride, Sodium
carbonate; Novex: Nickel affinity column; Roche: DNAse; RPI: Terrific broth media;
Sigma-Aldrich: Sodium chloride, Glycerol, Folin reagent; Sigma: ATP, GTP, CTP, and
TTP, L-aspartate, Sodium acetate, Antipyrine, Diacetyl monooxime, Dihydroorotate,
Sodium phosphate, Sodium hydroxide, Imidazole, Brilliant blue stain, Carbamoyl
aspartate, Carbamoyl phosphate; Thermo-Fisher: bis(sulfosuccinimidyl)suberate
(BS3), Sypro.
Protein Expression
Prior to all experiments, the ATCase and DHOase protein sequence of Bacillus
anthracis was aligned with multiple other species to see homologies among species. Our
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species retained all important active sites conserved among the other species. Bacterial
expression of the proteins were performed. Bacillus anthracis ATCase and DHOase
plasmids were transfected into BL21(DE3) E. coli cells. Cells were then grown to an
optical density of 0.6 at 700 nm wavelength and harvested by centrifugation at 2000 RPM
for 50 minutes. The bacteria plasmid was then added to 20ul of BL21(DE3) competent
cells in 1 ml recovery media. The reactions were incubated at 37°C and plated on LB
ampicillin plates. The plates were then incubated at 37°C overnight.
Cell Growth and Harvesting
Single colonies were inoculated into 10 mL TB media. Stocks were then saved at
-80°C in 25% glycerol. All cells were grown to an optical density (OD) of approximately
0.6 absorbance units at 600nm wavelength. They were then induced with 1mM IPTG
overnight at 20°C. The cells were harvested using centrifugation at 2000 rpm for 50
minutes.
Protein Purification
The enzyme was purified using Ni-column chromatography and gel
filtration. Ni-columns have the ability to bind His6 tagged proteins to the nickel in the
column. The column was washed with purification buffer followed by increasing Imidazole
solutions to elute the tagged protein. Imidazole competes for binding with the protein to
the nickel column. Gel filtration, or size exclusion chromatography was done to remove
any contaminants. A S200 column of approximately 120 ml was used to purify the large
proteins. The protein concentration was checked with the Lowry assay, using bovine
serum albumin as the standard. The molecular mass of the recombinant proteins was
determined by gel filtration on an AKTA chromatography system. A Ni2+ column can
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purify his-tagged DHOase and ATCase. A Superdex S-200 column was calibrated with
50 mM Tris-HCl, pH 7.5, 200 mM NaCl, and 1 mM dithiothreitol. A sample of purified
protein was applied and eluted with the same buffer at a flow rate of 1 mL/min.

CHAPTER 3: ASSAYS
Lowry Assay
A Lowry assay was used to determine the concentration of each enzyme after
expression and purification. These concentrations were determined by using bovine
serum albumin 1mg/ml as a standard.
Calorimetric ATCase and DHOase Activity Assays
Assays were then performed of the enzymes. Activity assays such as the ATCase
calorimetric assay was performed. The assay was performed using 0.01M carbamoyl
aspartate, 48mM carbamoyl phosphate, 0.3M L-aspartate, 0.1M Tris-OAc at pH 8.3,
antipyrine reagent, and color mix. The reactions were incubated at 37°C for exactly two
minutes and then quenched with 5% acetic acid. The reaction mixtures were then
incubated at 60°C for one hour. The activity was measured by checking the absorbance
at 466nm using a DU70 spectrophotometer.
A DHOase colorimetric assay was also performed. The assay was performed
using 5mM carbamoyl aspartate, 8mM Dihydroorotate, 0.1M Tris-OAc at pH 8.3,
antipyrine reagent, and antipyrine/diacetyl monooxime color mix. The reactions were
incubated at 37°C for exactly two minutes and then quenched with 5% acetic acid. The
reaction mixtures were then incubated at 60°C for one hour. The activity was measured
using a DU70 spectrophotometer.
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Crosslinking
The crosslinking assay was used to isolate and characterize the two enzymes in
a protein protein interaction. This assay was able to freeze and capture the two proteins
bound to each other. 50 nM protein concentrations were added to 1mM BS3. 10 ul
aliquots were then taken from the reaction after 0, 5, 10, 30 60, and 120-minute intervals
and quenched with 10ml 1M Tris, pH 8. Characterization was then shown using sodium
dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Thermal Shift Assay
A thermal shift assay was done to detect the enzymes’ thermal stability. It
determined the protein’s melting temperature to find its thermal stability. It was also able
to identify intramolecular and intermolecular interactions. The assay was done in a 96well PCR microplate from Applied Biosystems. Each well contained 1 ul of purified
protein, 1 ul 500X SYPRO Orange dye (5000X diluted into buffer), and 23 ul buffer
(50mM sodium phosphate pH 7.5, 500mM NaCl, and 5% glycerol). An adhesive plastic
cover was applied to the plate and was centrifuged manually 5 times. The melting
temperatures of the enzymes were calculated by the first derivative of the fluorescence
vs. temperature plot using the Applied Biosystems 7500 software.
Nucleotide Inhibition Assay
An activity assay was used to screen inhibitors such as nucleotides, which act on
these enzymes. This was done using the colorimetric assay. Enzyme kinetics was
performed to determine the enzyme’s activity. Inhibition was determined to measure the
affinity of the enzyme. Steady-state kinetics was performed using different inhibitors to
determine whether the inhibitor is competitive or noncompetitive. The ATCase assay was
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performed using 2mM aspartate, 50mM Tris/Acetate buffer of pH 8.3, 2-3 µg purified
ATC in 1 ml volume, 2 ml color mix (antipyrine/diacetyl monooxime) and was incubated
at 60°C for one hour. The reaction was initiated with 0-5 mM carbamoyl phosphate for 2
minutes at 37°C. DHOase activity was initiated with 0-8mM DHO for 2 minutes at 37°C.
The assay was performed with 50mM Tris acetate buffer at pH 8.3, 25 µg purified DHO
in 1 ml volume, and 2 ml color mix.

CHAPTER 4: RESULTS
Protein Purification and Expression
Bacillus anthracis ATCase and DHOase were expressed and purified as shown
in Figure 1 (ATCase) and Figure 2 (DHOase).
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Figure 1. Expression and purification of ATCase. Ladder, pellet, super (supernatant), FT
(flow through). The protein was then eluted with 0mM Buffer, 25mM imidazole, 50 mM
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imidazole, and 250mM imidiazole (elute 1, elute 2, elute 3, elute 4, elute 5 and elute 6)
of 4 ml elutions each.
Ladder Pellet Super. FT
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Figure 2. Expression and purification of DHOase. Ladder, pellet, super (supernatant), FT
(flow through). The protein was then eluted with 0mM Buffer, 25mM imidazole, 50 mM
imidazole, and 250mM imidiazole (elute 1, elute 2, elute 3, elute 4, elute 5, elute 6, elute
7, and elute 8) of 4 ml elutions each.
The fractions containing protein (Figure 1 fractions 9-14 and Figure 2 fractions 915) were pooled and the protein concentration was determined by a Lowry assay. The
concentration of the purified proteins was 5mg/ml for ATCase and 8 mg/ml for DHOase.
Lowry Assay
A Lowry assay was preformed to determine the concentration of each enzyme. ATCase
had a concentration of 5 mg/ml and DHOase had a concentration of 8mg/ml.
Native Gel
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Native gel electrophoresis was preformed determine the formation of the ATCase
DHOase complex. This is shown in figure 3. A stable ATCase DHOase complex was
observed in Aquifex aeolicus. [23] However, there is no complex formation in Bacillus
anthracis.

1236
1048
720

Ladder

ATCase

DHOase

DAC

480

242
146

DHOase
66

ATCase

20
Figure 3. Native gel of native ladder, ATCase, DHOase, and DAC. The lane labeled DAC
consisted of equimolar mixture of purified ATCase 10µg and DHOase 10µg.
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DAC showed sample bands corresponding o both ATCase and DHOase and no
higher molecular weight species suggesting that these proteins do not associate to form
a complex.
Enzymatic Activity of ATCase and DHOase
An assay was performed to determine each enzyme’s activity. A standard curve
of differing concentrations of carbamoyl aspartate was also generated. The activity of
each protein was determined using multiple concentrations of enzyme. ATCase was
found to have a specific activity of about 10 µmol/min/mg. DHOase was found to have a
specific activity of 5 µmol/min/mg. Saturation curves were produced using increasing
concentrations of substrate. The ATCase saturation curve was fit to a Michaelis Menten
equation and was found to have a Km value of 1.40 ± 0.50 and a Vmax value of 15.78
± 2.7. The DHOase was also fit to a Michaelis Menten equation and the Km was found
to be 1.09 ± 0.31 and a Vmax value of 8.07 ± 0.60. The saturation curve of ATCase is
shown in Figure 4. The saturation curve of DHOase is shown in Figure 5.

ATCase Carbamoyl Phosphate Saturation Curve
12

Specific Activity
(umol/min/mg)

10

8

6

y = m0*m1/(M2+M0)

4

m1
m2
Chisq
R

2

Value
15.775
1.4025

Error
2.7437
0.4977

4.838
0.97894

NA
NA

0
0

0.5

1

1.5

2

Carbamoyl Phosphate (mM)

2.5

3

13
Figure 4. Saturation curve of ATCase with increasing concentrations of substrate,
carbamoyl phosphate.
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DHOase Dihydroorotate Saturation Curve
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Figure 5. Saturation curve of DHOase with increasing concentrations of substrate,
dihydroorotase.
The assay was then repeated using 5000umol carbamoyl aspartate and
8000umol dihydroorotate. Varying amounts of one enzyme was added to consistent
volumes of the other constant. The titrations were performed in 1:0.2, 1:0.4, 1:0.6, 1:0.8,
1:1, 1:2, 1:3, 1:4, and 1:5 ratios. The titration of ATCase with DHOase is shown in figure
6. The titration of DHOase with ATCase is shown in figure 7. Activity does not significantly
increase, which shows that the two do not form a complex or if complex formation occurs,
it has no effect on activity.
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Specific Activity (umol/min/mg)

ATCase Titration with DHOase
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Figure 6. Titration of ATCase with differing amounts of DHOase in the presence of 5
mmol carbamoyl aspartate.
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Figure 7. Titration of DHOase with differing amounts of ATCase in the presence of 8
mmol dihydroorotate.
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Thermal Shift Assay
A thermal shift assay was done to detect the proteins melting temperature to
assess its thermal stability. A ratio of 1:1, SYPRO reagent to protein provided the best
melt curve. The derivative of the melt curve for ATCase is shown in Figure 8. The
derivative of the melt curve for DHOase is shown in Figure 9. The melting temperature
for ATCase was 74°C. The melting temperature for DHOase was 63°C. The DHOase
ATCase (DAC) mixture had a melting point of 72°C, showing that it is ATCase dominant
and is actually less stable than the enzymes alone. This shows that the mixture is not
stable and therefore does not form under normal conditions. The thermal shift for the
ATCase DHOase mixture (DAC) is shown in Figure 10.
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Figure 8. Thermal shift assay results of the melting curve derivative and melting
curve temperature for ATCase.
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Figure 9. Thermal shift assay results of the melting curve derivative and melting
curve temperature for DHOase.
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Figure 10. Thermal shift assay results of the melting curve derivative and melting
curve temperature for the ATCase DHOase (DAC) mixture.
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Effect of Nucleotides on Bacillus anthracis Inhibition Assay
The colorimetric assay described above was used to screen inhibitors such as
nucleotides. Differing concentrations of the nucleotides ATP, GTP, CTP and TTP were
added to a consistent concentration of enzyme. The effects of nucleotides on ATCase
are shown in figures 11a through 11d. The effects of nucleotides on DHOase is shown
in figures 12a through 12d. All the nucleotides tested (ATP, GTP, TTP, and CTP) show
no effect on activity.
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Figure 11a-11d. Activity assay showing the effects of ATP, GTP, CTP, and TTP on
ATCase respectively.
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Figure 12a-12d. Activity assay showing the effects of ATP, GTP, CTP, and TTP on
DHOase respectively.
Protein Characterization and Determination
Gel filtration on a 200-S column Akta filtration machine was used to determine the
oligomeric structure of ATCase, DHOase, and their mixture. Gel filtration is a type of
native or nondenaturing filtration. So, the proteins can be visualized in their natural
oligomeric state. SDS- PAGE can be used to visualize the individual monomeric proteins
or subunties because the SDS acts as a denaturing agent, breaking down the protein to
its primary structure. A mixture of standard molecules (vitamin B12, myoglobin,
ovalbumin, γ-globulin, and thyroglobulin) was run on the system, giving a standard linear
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equation of y=-23.062x+114.5. This was used to calculate the molecular weight of the
enzymes. Previous studies have suggested that ATCase and DHOase form a complex,
yet they do not rely on each other for catalytic activity. [24] ATCase as a monomer has
a molecular weight of 35 kDa. The molecular weight of ATCase was found to be about
89 kDA, so that the ratio of oligomer/monomer (89/35) is 2.54 suggesting that ATCase
is a trimer. The ATCase peak is shown in Figure 13. DHOase as a monomer has a
molecular weight of 47kDa. The molecular weight of DHO was found to be 76.5 kDa
indicating that it is a dimer. The DHOase peak is shown in Figure 14. The peak of the
DAC mixture is shown in Figure 15. When the two enzymes were loaded together on the
gel filtration system, there is a peak at the same position where DHOase alone or
ATCase alone would elute. The mass of the ATCase timer and DHOase dimer is 89 kDa
and 77 kDa respectively, so the peaks are for the most part superimposed. However,
there is no high molecular weight species corresponding to a higher oligomer kDa. When
calculated, the molecular weight was 76 kDa, which is close to the molecular mass of
the two enzymes’, assuming that the ATCase and DHOase form trimers and dimers
respectively. If it formed a complex there would be a narrow peak at a slightly higher
molecular weight of at least 166 kDa. This result provides further evidence suggesting
that the two proteins do not form a complex.
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Figure 13. Gel filtration peak of ATCase.
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DHOase B. anthracis
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Figure 14. Gel filtration peak of DHOase.
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DAC B. anthracis
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Figure 15. Gel filtration peak of DAC mixture.

CHAPTER 5: CONCLUSIONS
The equimolar mixture between Bacillus Anthracis aspartate transcarbamoylase
and dihydroorotase slightly increased activity as opposed to the two enzymes separately.
All nucleotides had little to no effect on ATCase or DHOase activity. ATCase had a melting
temperature of 74°C. DHOase had a melting temperature of 63°C. The complex DAC had
a melting temperature of 72°C. Gel filtration provides further evidence that unlike other
systems, the ATCase and DHOase probably do not associate to form a stable complex.
ATCase was found to have a molecular weight of about 37 kDa but when
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chromatographed on a size exclusion column, it showed a molecular weight of about 80
kDa showing that it is a trimer. DHOase was found to have a molecular weight of about
45 kDa but gel filtration gave a molecular weight of about 90 kDa showing that it is a
dimer. Both ATCase and DHOase are active in Bacillus anthracis, unlike that of
Pseudomonas aeruginosa which exhibits a pseudo DHOase. The structure of DHOase in
Bacillus anthracis has already been determined, but future work should be carried out to
crystalize and determine the 3D structure of ATCase.
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APPENDIX
All research was performed through Wayne State University School of Medicine.
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There are many enzymes required for efficient and proper pyrimidine biosynthesis.
The two that are most important and were discussed in this thesis are aspartate
transcarbamoylase (ATCase) and dihydroorotase (DHOase). Both play an important role
in not only pyrimidine biosynthesis production, but also mechanistic regulation of de novo
synthesis. Anthrax is an infection caused by Bacillus anthracis. Here we studied ATCase
and DHOase in Bacillus Anthracis. In this thesis we understood the effects of the enzymes
ATCase and DHOase on pyrimidine biosynthesis. Adequate inhibitors of these enzymes
would result in cell death and could pose as a cure to infection by Bacillus Anthracis or
anthrax. This research showed the effects of inhibitors on the thermal stability, binding
ability, and activity of the two enzymes alone. Specifically, we saw that ATCase and
DHOase do not form a complex. Nucleotides had little regulatory properties on ATCase
or DHOase. The biochemical and structural aspects given by these enzymes is important
to human health and will lead to a better understanding of diseases such as bacteremia
and anthrax.
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